Independence Blue CrossCommercial · Coverage · Medical Policy · Transplant Surgery, Nephrology, Infectious Disease +1 moreLow impact
06.02.37a, Immune Cell Function Assay
Effective date
Not stated in the notice
Identified
Jun 19, 2026
Summary
Independence Blue Cross reissued Policy 06.02.37a with no substantive changes. The policy continues to classify Immune Cell Function Assay (CPT 86352) as experimental/investigational and not covered for all indications, including transplant monitoring. This is a routine annual review reissuance with no workflow impact.
Get alerts when payers change rules like this one
We check Independence Blue Cross and other payers every day and email you when a change matches your specialty and state.
Summaries are AI-assisted. Always confirm against the original payer notice.
What is PolicyChanges
One workspace for payer rules, prior auth, coding and compliance
Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.